Henry Schein is a Fortune 500 company and one of the global leaders in its industry, providing healthcare solutions, as well ...
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq ... Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more ...
Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises ...
Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...
The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...
Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...
Dental supply company Henry Schein reported total net sales of $3.2 billion during the third quarter of 2024, according to a Nov. 5 financial report. Here are eight things to know: 1. Third-quarter ...
On Tuesday, Henry Schein Inc. (NASDAQ ... market share in our dental and medical distribution businesses following last year's cyber incident. Our dental equipment business is showing ongoing ...